Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Comment by oxinoson Nov 04, 2020 12:37pm
126 Views
Post# 31836072

RE:We should make good return even with $.02 to $.03 per Cube

RE:We should make good return even with $.02 to $.03 per Cube
Sarb99 wrote: Just say $200,000 revenue per cube, per month and $2.4 million per year with 50% profit margin is $1.2 million profit per year per cube. Now we can do it $1,200,000x5=$6 million per cube and now $6/150 million shares outstanding comes to $.04 cents. So, $.02 to $.04 per cube should be good calculation, as you feel comfortable $.02 or $.04 cents.
 
  1. Now lets say QuestCap launch 165 covid-19 testing centres 165x$.02=$3.30 per share or 165x$.03=$4.95 per share.
  2. Now Lets say QuestCap launch 500 covid-19 testing centres by year end or even in January 500x$.02=$10 per share or 500x$.03 = $15 per share.
  3. Should I calculate 1000 or 2000 testing centres by the end of the first quarter of 2021 “Nah” we will do that later.
  4. When QuestCap file financial at the end of this month if nothing else. We will see what kind of revenue they are making from Columbia S.A. Then we can add that to our calculations.



Sarb 99 I like your assumptions but I would be happy to see us reach a stock valuation of one half of 1 cent per questcube. Before we walk we must learn how to crawl. Let's get to $1.00, the 52 week high, and then we can contemplate the higher numbers.

<< Previous
Bullboard Posts
Next >>